Katherine Beebe - Jan 5, 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
President and COO, Director
Signature
/S/ Kate Beebe Devarney
Stock symbol
TTNP
Transactions as of
Jan 5, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 05:50 PM
Next filing
Jul 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTNP Option to Purchase Common Stock Award $0 +55K $0.00 55K Jan 5, 2022 Common Stock 55K $1.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter.